Fact CheckerSign in

NCT05991297Completed

Effects of Deep Sensory Assisted Rehabilitation on Gait and Balance in Patients With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

The effect of physical therapy and rehabilitation on improving the gait and balance disorders of patients has been proven. FTR applications in MS patients have become routine in developed countries. However, due to the high patient density in our country, FTR cannot be performed at the rate we want due to different reasons such as the inability to separate areas special for MS patients, the lack of special FTR applications for MS patients, and the inability to perform regular FTR follow-ups. Even if FTR is recommended and performed, our patients think that FTR is not very effective due to the above reasons and they do not continue. A team of neurology, physical therapy specialists, and physiotherapists was formed, in-service training was completed and a special rehabilitation program for MS patients was created. First of all, we will apply routine classical FTR to our patients. Sensory and deep sensory disorders, which are more common and severe, especially in the lower extremities, also negatively affect gait and balance. A rehabilitation program was created by adding exercises to improve sensation and deep sense, along with muscle strengthening. The results of the 1st and 21st sessions of the patients in the two groups who underwent classical rehabilitation and deep sensory-assisted rehabilitation will be compared. It was planned to evaluate the gait and balance parameters of the patients as numerical data with clinical scales and the C mill device we used in walking and balance exercises.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
26 Jul 2023
Start date
1 Jun 2023
Primary completion date
1 Feb 2024
Lead sponsor
Nermin Çalışır
NCT number
NCT05991297

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 1 Jun 2023 to the primary completion date, 1 Feb 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • schizoaffective disorder
  • diabetes mellitus
  • cognitive impairment (at a level that may interfere with communication)

Other

  • lower extremity amputation
  • shortness on one side creating asymmetry in the lower extremities

Who the study is looking for

  • Diagnosed with multiple sclerosis
  • 20-60 years old
  • EDSS between 3.0-5.5 Those with EDSS 0-2.5 and spinal and/or cerebellar involvement
  • Had the last MS attack at least 3 months ago

Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Romatem Physical Therapy and Rehabilitation Hospitals Bursa Hospital
Coordinator of this site? Confirm its status
BursaTurkey (Türkiye)Unknown status
University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
Coordinator of this site? Confirm its status
BursaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.